Literature DB >> 23492607

From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence.

E P Navarese1, F Castriota, G M Sangiorgi, A Cremonesi.   

Abstract

The implementation of methods of the coronary angioplasty was one of the most important achievement in the field of treatment of coronary artery disease. Abluminal biodegradable polymer stents (BDS) and polymer free stent are the newest and the most promising research concerning coronary stent technology. In this article we discuss the perceived need for BDS-polymer free stents, the current clinical evidence, limits and future perspectives.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23492607

Source DB:  PubMed          Journal:  Minerva Cardioangiol        ISSN： 0026-4725            Impact factor:   1.347


  2 in total

1.  Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials.

Authors:  Eliano Pio Navarese; Felicita Andreotti; Volker Schulze; Michalina Kołodziejczak; Antonino Buffon; Marc Brouwer; Francesco Costa; Mariusz Kowalewski; Gianfranco Parati; Gregory Y H Lip; Malte Kelm; Marco Valgimigli
Journal:  BMJ       Date:  2015-04-16

2.  Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

Authors:  Eliano P Navarese; Kenneth Tandjung; Bimmer Claessen; Felicita Andreotti; Mariusz Kowalewski; David E Kandzari; Dean J Kereiakes; Ron Waksman; Laura Mauri; Ian T Meredith; Aloke V Finn; Hyo-Soo Kim; Jacek Kubica; Harry Suryapranata; Toni Mustahsani Aprami; Giuseppe Di Pasquale; Clemens von Birgelen; Elvin Kedhi
Journal:  BMJ       Date:  2013-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.